Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study

Published:2022 Issue:2 Volume:71 Page:158-164
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Hamaguchi Masahide¹,Yoshimura Yuta¹,Nakajima Hanako¹,Tanaka Toru²,Hasegawa Goji³,Ishii Michiyo⁴,Okada Hiroshi⁵,Mitsuhashi Kazuteru⁶,Kitagawa Noriyuki⁷,Okamura Takuro¹,Hashimoto Yoshitaka¹,Majima Saori¹,Senmaru Takafumi¹,Ushigome Emi¹,Nakanishi Naoko¹,Asano Mai¹,Yamazaki Masahiro¹,Fukui Michiaki¹,

Affiliation:

1. Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine

2. Department of Diabetes and Endocrinology, Japanese Red Cross Kyoto Daiichi Hospital

3. Division of Metabolism, Nephrology and Rheumatology, Japanese Red Cross Kyoto Daini Hospital

4. Department of Internal Medicine, Otsu City Hospital

5. Department of Diabetes and Endocrinology, Matsushita Memorial Hospital

6. Department of Diabetes Internal Medicine, Fukuchiyama City Hospital

7. Department of Diabetology, Kameoka Municipal Hospital

Publisher

The Society for Free Radical Research Japan

Subject

Clinical Biochemistry,Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.jstage.jst.go.jp/article/jcbn/71/2/71_22-7/_pdf

Reference23 articles.

1. 1 American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019; 42(Suppl 1): S90–S102.

2. 2 Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract 2008; 14: 1095–1101.

3. 3 Kuroda A, Kaneto H, Yasuda T, et al. Basal insulin requirement is ∼30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump. Diabetes Care 2011; 34: 1089–1090.

4. 4 King AB. How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring. Endocr Pract 2010; 16: 428–432.

5. 5 Edqvist J, Rawshani A, Adiels M, et al. BMI, mortality, and cardiovascular outcomes in type 1 diabetes: findings against an obesity paradox. Diabetes Care 2019; 42: 1297–1304.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of celiac disease in patients with type 1 diabetes mellitus: a single-center cross-‍sectional cohort study;Journal of Clinical Biochemistry and Nutrition;2024

2. Effects of dapagliflozin on renal function in type 1 diabetes patients in the real world: A retrospective multicenter study of the KAMOGAWA-A cohort;Diabetes Research and Clinical Practice;2023-08

3. Changes in glycemic control and skeletal muscle mass indices after dapagliflozin treatment in individuals with type 1 diabetes mellitus;Journal of Diabetes Investigation;2023-07-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3